Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NIH3D

Adagrasib

PubChem 138611145
was used by NIH 3D workflows to automatically generate models for
Antoine Simoneau
Created:
8/12/24
Submitted:
10/9/26
Published:
10/9/26

Select an image below to view

Learn more about NIH 3D workflow outputs

3DPX-021328

Licensing:

CC-BY
171
48
Version 2

Category

Small Molecules
Small Molecules
Description

Adagrasib (MRTX849) is an oral, small-molecule KRAS inhibitor developed by Mirati Therapeutics. KRAS mutations are highly common in cancer and account for approximately 85% of all RAS family mutations.
https://pubchem.ncbi.nlm.nih.gov/image/imagefly.cgi?cid=138611145&width=400&height=400